TheraBionic P1 Clinical Trials
3 recruitingDevice
Phase 22Not Applicable1
Showing 1–3 of 3 trials
Recruiting
Not Applicable
TheraBionic P1 Device in Subjects With Advanced Hepatocellular Carcinoma
Hepatocellular Carcinoma Recurrent
Barbara Ann Karmanos Cancer Institute198 enrolled6 locationsNCT07118202
Recruiting
Phase 2
Amplitude-Modulated Radiofrequency Electromagnetic Fields (AM RF EMF) in Combination With Fruquintinib in Refractory Metastatic Colorectal Cancer
Metastatic Colorectal Adenocarcinoma
Barbara Ann Karmanos Cancer Institute102 enrolled9 locationsNCT07130903
Recruiting
Phase 2
Gemcitabine, Nab-paclitaxel Plus the TheraBionic P1 (an Amplitude-Modulated Radiofrequency Electromagnetic Fields) Device to Treat Metastatic Pancreatic Cancer
Metastatic Pancreatic Adenocarcinoma
Barbara Ann Karmanos Cancer Institute30 enrolled7 locationsNCT06576115